This survey assesses CAR T cell therapy use in DLBCL, focusing on educational gaps in awareness, barriers to use, and adverse event management. Your confidential input will optimize clinical practice and improve outcomes. Participants will be remunerated for their time. Thank you for sharing your expertise!
This message is being sent as part of CAPhO’s Email Distribution Service on behalf of Synapse Medical Communications Inc. and is not an endorsement or recommendation of the product or message content.